The CI\u2019s track record wasn\u2019t disclosed but the corrobation was. Probable cause was shown. \u201cHere, Detective Shelton’s affidavit established probable cause. Shelton’s affidavit relayed the informant’s statement that Defendant Butts was manufacturing Fentanyl tablets using Drug Mart brand pain medication. Though Shelton’s affidavit did not describe the informant’s track record, the investigating officers, as detailed in the affidavit, verified the informant’s reliability through their corroborative police work.\u201d United States v. Butts, 2020 U.S. Dist. LEXIS 232365 (N.D. Ohio Dec. 10, 2020).<\/p>\n\n\n\n
Objections to the search raised for the first time in response to the R&R are waived. United States v. Redman, 2020 U.S. Dist. LEXIS 232306 (N.D. Iowa Dec. 10, 2020).*<\/p>\n","protected":false},"excerpt":{"rendered":"
The CI\u2019s track record wasn\u2019t disclosed but the corrobation was. Probable cause was shown. \u201cHere, Detective Shelton’s affidavit established probable cause. Shelton’s affidavit relayed the informant’s statement that Defendant Butts was manufacturing Fentanyl tablets using Drug Mart brand pain medication. … Continue reading